Brief: Edgewise Therapeutics Announces Pricing Of $200 Million Underwritten Offering Of Common Stock
02/04/2025 11:35
April 2 (Reuters) - Edgewise Therapeutics Inc EWTX.O: EDGEWISE THERAPEUTICS ANNOUNCES PRICING OF $200 MILLION UNDERWRITTEN OFFERING OF COMMON STOCK EDGEWISE THERAPEUTICS - PRICING OF UNDERWRITTEN OFFERING OF 9.9 MILLION SHARES OF COMMON STOCK AT OFFERING PRICE OF $20.13 PER SHARE Source text: ID:nPnb0Ywpla Further company coverage: EWTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending